Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonists.

ABSTRACT: Anti-apoptotic Bcl-2 family proteins such as Bcl-2 and Bcl-X(L) have been recently validated as targets for the discovery of novel anti-cancer agents. We previously reported that racemic (+/-) Apogossypol, a semi-synthetic compound derived from the natural product Gossypol, binds and inhibits Bcl-2 and Bcl-X(L)in vitro and in cell. Given that (+) and (-) Gossypol display different proapoptotic activities, here we report on the synthesis of (+) and (-) Apogossypol and the evaluation of their in vitro and cellular activity.

SUBMITTER: Wei J 

PROVIDER: S-EPMC2653056 | biostudies-literature | 2009 Jan

REPOSITORIES: biostudies-literature